We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
HHS should seek to recover the government salary paid to a former high-ranking official for concealing from Congress higher cost estimates, technical assistance and data for the Medicare prescription drug bill, according to a new legal opinion from the Government Accountability Office (GAO).
As part of its continuing effort to accelerate drug development, the FDA’s Pharmaceutical Science Advisory Committee will meet Oct. 19 to evaluate research opportunities under the agency’s Critical Path Initiative.
The FDA is not giving up the drug importation fight, despite a growing demand for what still are illegally imported prescription drugs and the abetting of such importation by a growing number of state and local governments.
HHS and the FDA said they would “vigorously” defend themselves against allegations that the agencies are not acting quickly enough to establish a program that would allow the legal importation of prescription drugs from Canada.
According to at least one pharmaceutical analyst, the U.S. Pharmacopeia’s (USP’s) proposed guidelines for developing Medicare drug formularies could make it difficult for some brand products to make the cut.
Gov. Arnold Schwarzenegger has sent a letter to HHS detailing two different approaches that he believes would help low-income uninsured Californians buy prescription drugs by forcing pharmaceutical manufacturers to negotiate prices.
Canadians are paying hundreds of millions of dollars more for generic drugs each year than they would be in the absence of government policies that encourage inflated prices, according to a study by the Fraser Institute, a free market public policy organization based in Canada.
Despite a growing demand for what still are illegally imported prescription drugs and the abetting of such importation by a growing number of state and local governments, the FDA is not giving up the fight.
The FDA has concluded there is evidence to suggest an increased risk of suicidal behavior for children using certain antidepressant medications, a conclusion that at least partially vindicates findings made by FDA scientist Andrew Mosholder months ago.
The state of Illinois is about to introduce a prescription drug importation program that goes far beyond anything any other state or municipality has so far attempted.